The Biomanufacturing Excellence Act creates a national Center of Excellence to drive innovation in biopharmaceutical ...

Study shows social isolation following immune challenge is self-imposed and driven by an active neural process, rather than a secondary consequence of physiological symptoms of sickness.

This academic-industry partnership reflects the need for a multidisciplinary approach to innovation in cell and gene therapy manufacturing.

EVE is a deep generative model combining evolutionary and human population data to estimate variant deleteriousness on a proteome-wide scale.

Scripps Research uses advanced AI computing to speed HIV vaccine development by rapidly analyzing clinical data.

The Fugaku supercomputer builds a highly detailed virtual mouse cortex with millions of neurons enabling unprecedented ...

The U.S. is AstraZeneca’s largest market by sales and is also home to 19 R&D, manufacturing, and commercial sites.

Sustainable bioprocessing boosts cyanobacterial pigment production for advanced biomedical, imaging, and commercial applications.

Two new antibodies may treat autoimmune diseases by reducing inflammation through blocking the immune receptor FcγRI.

Prophylactic HPV vaccines prevent infection but not existing disease. A nasal nanogel vaccine shows preclinical promise for ...

The surprising findings could improve how doctors manage type 1 diabetes and ease the significant burden that people with the condition face when using insulin alone. In their published paper in ...

The U.S. Pharmacopeia has created new standards to support the emerging field of advanced cell and gene therapies.